NO20061657L - Pyrolderivater med antibakteriell aktivitet - Google Patents

Pyrolderivater med antibakteriell aktivitet

Info

Publication number
NO20061657L
NO20061657L NO20061657A NO20061657A NO20061657L NO 20061657 L NO20061657 L NO 20061657L NO 20061657 A NO20061657 A NO 20061657A NO 20061657 A NO20061657 A NO 20061657A NO 20061657 L NO20061657 L NO 20061657L
Authority
NO
Norway
Prior art keywords
pyrol
derivatives
antibacterial activity
drugs
compounds
Prior art date
Application number
NO20061657A
Other languages
English (en)
Norwegian (no)
Inventor
David Timms
George Mullen
Neil James Hales
Sheila Irene Hauck
Alexander Louis Breeze
Oluyinka Morenike Green
Kenneth Gregory Hull
Haibong Ni
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0321509A external-priority patent/GB0321509D0/en
Priority claimed from GB0410527A external-priority patent/GB0410527D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20061657L publication Critical patent/NO20061657L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/63Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
    • C04B35/632Organic additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Ceramic Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Structural Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20061657A 2003-09-13 2006-04-11 Pyrolderivater med antibakteriell aktivitet NO20061657L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0321509A GB0321509D0 (en) 2003-09-13 2003-09-13 Chemical compounds
GB0410527A GB0410527D0 (en) 2004-05-12 2004-05-12 Chemical compounds
PCT/GB2004/003874 WO2005026149A1 (en) 2003-09-13 2004-09-10 Pyrrol derivatives with antibacterial activity

Publications (1)

Publication Number Publication Date
NO20061657L true NO20061657L (no) 2006-06-13

Family

ID=34315434

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061657A NO20061657L (no) 2003-09-13 2006-04-11 Pyrolderivater med antibakteriell aktivitet

Country Status (19)

Country Link
US (1) US7709503B2 (de)
EP (1) EP1664025B1 (de)
JP (1) JP4959329B2 (de)
KR (1) KR20070026318A (de)
AR (1) AR046160A1 (de)
AT (1) ATE373650T1 (de)
AU (1) AU2004272338B2 (de)
BR (1) BRPI0414330A (de)
CA (1) CA2538552A1 (de)
DE (1) DE602004009089T2 (de)
ES (1) ES2291934T3 (de)
IL (1) IL174165A0 (de)
IS (1) IS8403A (de)
MX (1) MXPA06002847A (de)
NO (1) NO20061657L (de)
RU (1) RU2006112046A (de)
TW (1) TW200526626A (de)
UY (1) UY28510A1 (de)
WO (1) WO2005026149A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861070B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
WO2006053227A2 (en) * 2004-11-10 2006-05-18 Synta Pharmaceuticals Corp. Il-12 modulatory compounds
EP1856103A2 (de) * 2005-02-18 2007-11-21 AstraZeneca AB Pyrrolderivate als dna-gyrase- und topoisomeraseinhibitoren
JP4058106B2 (ja) * 2005-02-18 2008-03-05 アストラゼネカ アクチボラグ 抗菌性のピペリジン誘導体
WO2006092608A1 (en) * 2005-03-04 2006-09-08 Astrazeneca Ab Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
DK3421471T3 (da) 2006-04-25 2021-06-14 Astex Therapeutics Ltd Purin- og deazapurinderivater som farmaceutiske forbindelser
WO2008020229A2 (en) * 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
TW200819437A (en) * 2006-08-17 2008-05-01 Astrazeneca Ab Chemical compounds
WO2008020227A2 (en) * 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
EP1903038A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren
TW200906412A (en) * 2007-06-12 2009-02-16 Astrazeneca Ab Piperidine compounds and uses thereof
PL2201012T3 (pl) 2007-10-11 2014-11-28 Astrazeneca Ab Pochodne pirolo[2,3-d]pirymidyny jako inhibitory kinazy białkowej b
TWI498115B (zh) * 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
JP5524491B2 (ja) * 2008-03-04 2014-06-18 石原産業株式会社 3−アミノ−2−クロロ−6−トリフルオロメチルピリジンの製造方法
TW201026695A (en) 2008-12-12 2010-07-16 Astrazeneca Ab Piperidine compounds and uses thereof-596
TW201026694A (en) * 2008-12-12 2010-07-16 Astrazeneca Ab Compound 468
US8637678B2 (en) 2008-12-24 2014-01-28 Syngenta Limited Methods for the preparation of aryl amides
TW201102065A (en) 2009-05-29 2011-01-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
TWI598347B (zh) 2009-07-13 2017-09-11 基利科學股份有限公司 調節細胞凋亡信號之激酶的抑制劑
US20110065698A1 (en) 2009-08-26 2011-03-17 Cylene Pharmaceuticals, Inc. Novel protein kinase modulators
TW201111380A (en) 2009-08-26 2011-04-01 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
MX2012006776A (es) 2009-12-14 2012-10-05 Merck Patent Gmbh Inhibidores de la esfingosina quinasa.
EA201201171A1 (ru) 2010-02-22 2013-03-29 Зингента Партисипейшнс Аг Дигидрофурановые производные в качестве инсектицидных соединений
JP5996532B2 (ja) 2010-07-15 2016-09-21 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 有害生物防除剤としての新規複素環式化合物
EA027506B1 (ru) 2011-04-01 2017-08-31 Астразенека Аб Способ лечения рака молочной железы
JP5970537B2 (ja) * 2011-04-19 2016-08-17 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ キナーゼ阻害薬として活性な置換ピリミジニル−ピロール
US20140343049A1 (en) 2011-08-22 2014-11-20 Syngenta Participations Ag Dihydrofuran derivatives as insecticidal compounds
HRP20191982T4 (hr) 2011-11-30 2023-01-06 Astrazeneca Ab Kombinacijsko liječenje raka
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms
EP2818461A1 (de) 2013-06-26 2014-12-31 Lonza Ltd Verfahren zur Herstellung von 6-Trifluormethylpyridin-3-Carboxylsäurederivaten aus 4,4,4-Trifluor-3-Oxobutanoylchlorid
EP2821399A1 (de) 2013-07-04 2015-01-07 Lonza Ltd Verfahren zur Herstellung von 6-Trifluormethylpyridin-3-Carboxyl-Säurederivaten aus 4,4,4-Trifluor-3-Oxobutanoylchlorid
US9840489B2 (en) 2013-12-20 2017-12-12 Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China Piperidine carboxamide compound, preparation method, and usage thereof
EP3129344B1 (de) 2014-06-26 2017-10-18 Lonza Ltd Verfahren zur herstellung von 4-alkoxy-1,1,1-trifluorbut-3-en-2-one aus 1,1,1-trifluoraceton
JP6621477B2 (ja) * 2014-12-18 2019-12-18 ファイザー・インク ピリミジンおよびトリアジン誘導体ならびにaxl阻害薬としてのそれらの使用
CN112225699B (zh) 2014-12-23 2023-11-14 吉利德科学公司 制备ask1抑制剂的方法
EP3356361B1 (de) 2015-09-30 2020-07-08 Daiichi Sankyo Company, Limited Hydroxyalkylthiadiazolderivate
MA45782B1 (fr) * 2016-07-28 2021-12-31 Idorsia Pharmaceuticals Ltd Modulateurs du récepteur de cxcr7 pipéridine
HRP20210228T1 (hr) 2016-11-08 2021-03-19 Bristol-Myers Squibb Company Amidi pirola kao inhibitori alfa v integrina
CA3056571C (en) 2017-03-14 2021-11-23 Daiichi Sankyo Company, Limited N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives
CA3057431A1 (en) 2017-03-24 2018-09-27 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative
KR102700471B1 (ko) 2017-11-07 2024-08-28 브리스톨-마이어스 스큅 컴퍼니 알파 v 인테그린 억제제로서의 피롤로피라진 유도체
WO2019145460A1 (en) 2018-01-26 2019-08-01 Idorsia Pharmaceuticals Ltd Crystalline forms of the cxcr7 receptor antagonist (3s,4s)-1-cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide
KR102328682B1 (ko) 2018-08-27 2021-11-18 주식회사 대웅제약 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물
EP3847172A1 (de) 2018-09-03 2021-07-14 Univerza v Ljubljani Neue klasse von dna-gyrase- und/oder topoisomerase-iv-inhibitoren mit aktivität gegen grampositive und gramnegative bakterien
EA202191349A1 (ru) * 2018-11-15 2021-08-10 Ниппон Синяку Ко., Лтд. 1,3,4-оксадиазолон и фармацевтический препарат
WO2022129327A1 (en) 2020-12-17 2022-06-23 Univerza V Ljubljani New n-phenylpyrrolamide inhibitors of dna gyrase and topoisomerase iv with antibacterial activity
CN115466246B (zh) * 2021-06-11 2024-02-06 中国医学科学院药物研究所 吡咯酰哌啶胺类化合物及其用途
CN116003305B (zh) * 2023-01-31 2025-07-15 康化(上海)新药研发有限公司 一种5-乙基-2-吡咯甲酸的制备方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL23847A (en) 1964-08-07 1969-02-27 Merck & Co Inc Benzimidazoles useful as antifungals
US3963480A (en) 1973-04-11 1976-06-15 Sterling Drug Inc. Herbicidal pyrrole-2-carboxamides
US4046775A (en) 1973-04-11 1977-09-06 Sterling Drug Inc. 4,5-Dihalopyrrole-2-carboxamides
US4791112A (en) 1987-02-02 1988-12-13 The Boc Group, Inc. N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
US4912109A (en) 1987-02-02 1990-03-27 Boc, Inc. N-heterocyclic-N-(4-piperidinyl) amides and pharmaceutical compositions and methods employing such compounds
US5739135A (en) 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
FR2766488B1 (fr) * 1997-07-23 2000-02-18 Hoechst Marion Roussel Inc Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
WO1999006369A1 (en) * 1997-08-01 1999-02-11 University Of Florida Neuraminidase inhibitors
JP2003104971A (ja) 1999-08-12 2003-04-09 Wakunaga Pharmaceut Co Ltd 新規アニリド誘導体又はその塩及びこれを含有する医薬
JP2003520233A (ja) 2000-01-18 2003-07-02 バーテックス ファーマシューティカルズ インコーポレイテッド ジャイレースインヒビターおよびそれらの使用
AU2001232809A1 (en) 2000-01-18 2001-07-31 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
TWI284639B (en) 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
AU2001269821A1 (en) 2000-06-15 2001-12-24 Barbara Chen Cycloalkyl alkanoic acids as integrin receptor antagonists
EP1305308B1 (de) * 2000-07-26 2006-12-20 Smithkline Beecham Plc Aminopiperidin chinoline und ihre azaisosteren analoga mit antibakterieller wirkung
US6964966B2 (en) * 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
DOP2002000386A (es) 2001-05-30 2002-12-15 Warner Lambert Co Agentes antibacterianos
CN101284773A (zh) 2001-08-09 2008-10-15 小野药品工业株式会社 羧酸衍生物及以它为活性成分的药剂
EP1453810B1 (de) 2001-12-05 2009-03-18 Sanofi-Aventis Deutschland GmbH Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7183276B2 (en) 2002-02-28 2007-02-27 Takeda Pharmaceutical Company Limited Azole compounds
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
US7135469B2 (en) 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
JPWO2004089954A1 (ja) 2003-04-08 2006-07-06 大日本住友製薬株式会社 新規なカルバペネム化合物
DE10316081A1 (de) 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
SE0302116D0 (sv) 2003-07-21 2003-07-21 Astrazeneca Ab Novel compounds
GB0325956D0 (en) 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
US20050197336A1 (en) 2004-03-08 2005-09-08 Miikana Therapeutics Corporation Inhibitors of histone deacetylase
US7345043B2 (en) 2004-04-01 2008-03-18 Miikana Therapeutics Inhibitors of histone deacetylase
WO2006030975A1 (ja) 2004-09-17 2006-03-23 Takeda Pharmaceutical Company Limited ピペリジン誘導体およびその用途
PT1807077T (pt) 2004-10-22 2017-01-06 Janssen Pharmaceutica Nv Inibidores de quinase c-fms
WO2006047504A1 (en) 2004-10-22 2006-05-04 Janssen Pharmaceutica, N.V. Aromatic amides as inhibitors of c-fms kinase
JP2008530193A (ja) 2005-02-18 2008-08-07 アストラゼネカ アクチボラグ 化合物
EP1856103A2 (de) 2005-02-18 2007-11-21 AstraZeneca AB Pyrrolderivate als dna-gyrase- und topoisomeraseinhibitoren
JP4058106B2 (ja) 2005-02-18 2008-03-05 アストラゼネカ アクチボラグ 抗菌性のピペリジン誘導体
WO2006092608A1 (en) 2005-03-04 2006-09-08 Astrazeneca Ab Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
CN101171247A (zh) 2005-03-04 2008-04-30 阿斯利康(瑞典)有限公司 作为dna促旋酶和拓扑异构酶抑制剂的吡咯衍生物
BRPI0620196A2 (pt) 2005-12-23 2013-01-15 Astrazeneca Ab composto, processo para a preparaÇço do mesmo, composiÇço farmacÊutica, uso de um composto, e, mÉtodos para a produÇço de um efeito antibacteriano em um animal de sangue quente, para a inibiÇço de dna girase e/ou topoisomerase iv bacteriana em um animal de sangue quente e para o tratamento de uma infecÇço bacteriana em um animal de sangue quente

Also Published As

Publication number Publication date
HK1091491A1 (en) 2007-01-19
UY28510A1 (es) 2005-04-29
KR20070026318A (ko) 2007-03-08
IS8403A (is) 2006-04-07
US7709503B2 (en) 2010-05-04
JP4959329B2 (ja) 2012-06-20
RU2006112046A (ru) 2007-11-10
WO2005026149A1 (en) 2005-03-24
AU2004272338A1 (en) 2005-03-24
TW200526626A (en) 2005-08-16
ATE373650T1 (de) 2007-10-15
AR046160A1 (es) 2005-11-30
IL174165A0 (en) 2006-08-01
US20060223801A1 (en) 2006-10-05
MXPA06002847A (es) 2006-06-14
AU2004272338B2 (en) 2008-06-05
CA2538552A1 (en) 2005-03-24
BRPI0414330A (pt) 2006-11-07
EP1664025A1 (de) 2006-06-07
DE602004009089D1 (de) 2007-10-31
JP2007505092A (ja) 2007-03-08
EP1664025B1 (de) 2007-09-19
DE602004009089T2 (de) 2008-06-12
ES2291934T3 (es) 2008-03-01

Similar Documents

Publication Publication Date Title
NO20061657L (no) Pyrolderivater med antibakteriell aktivitet
NO20074703L (no) Antibakterielle piperidinderivater
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
NO20083250L (no) Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner
NO20062583L (no) Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet
NO20055421L (no) Kinolinderivater som fosfodiestrase-inhibitorer
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
NO20062591L (no) Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet
NO20075059L (no) Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase
NO20072689L (no) Tetrasykliske indolderivater som antivirale midler
NO20084872L (no) 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig
NO20092542L (no) Antibakterielle kinolin-derivater
NO20065904L (no) Terapeutiske forbindelser
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
NO20061839L (no) Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20055766L (no) Positive modulatorer av nikotinacetylcholinreseptorer
NO20064010L (no) Indazolderivater og farmasoytiske preparater inneholdelse slike
WO2006092599A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
NO20092655L (no) 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler
MXPA05013050A (es) Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos.
NO20052182L (no) Nye forbindelser
NO20092547L (no) Antibakterielle kinolin-derivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application